On May 23, 2019, it was determined that Suyash Prasad, Senior Vice President and Chief Medical Officer of Audentes Therapeutics, Inc. would depart from the Company, effective June 30, 2019. On May 24, 2019, it was determined that John Gray, Ph.D., Senior Vice President and Chief Technology Officer of the Company, would depart from the Company, effective May 31, 2019. On May 29, 2019, the Company announced the hiring of Edward R. Conner, M.D. as Senior Vice President and Chief Medical Officer, effective July 15, 2019, and the promotion of Fulvio Mavilio, Ph.D., to Senior Vice President of Translational Science.